BHG - Bright Health Group GAAP EPS of -$0.45 misses by $0.08 revenue of $1.6B misses by $200M reaffirms FY guidance
- Bright Health Group press release ( NYSE: BHG ): Q2 GAAP EPS of -$0.45 misses by $0.08 .
- Revenue of $1.6B (+41.6% Y/Y) misses by $200M .
- OUTLOOK
- Reaffirming 2022 Consolidated Revenue, MCR, and Adjusted EBITDA guidance
- Bright Health Group reaffirms total Revenue guidance of in the range $6.8 billion to $7.1 billion vs consensus of $7.06B with an expected enterprise Medical Cost Ratio between 90% and 94%.
- On a segment basis, Bright HealthCare end-of-year membership is expected to be approximately 1,000,000, while NeueHealth Revenue is expected to be approximately $2.2 billion.
- Intercompany Revenue elimination, comprised of payments from Bright HealthCare to NeueHealth for managing patient care and for network services, is expected to be approximately $1.2 billion.
- Adjusted EBITDA for 2022 is expected to be a loss of between $500.0 million and $800.0 million † .
For further details see:
Bright Health Group GAAP EPS of -$0.45 misses by $0.08, revenue of $1.6B misses by $200M, reaffirms FY guidance